Gain expert perspectives from Sara Hurvitz MD and Kevin Kalinsky MD MS FASCO on the most clinically relevant data for early and advanced breast cancers presented at the 2024 ASCO Annual Meeting
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/oncology/asco-2024-breast-cancer/22599-47299
- Start Date: 2024-08-14 05:00:00
- End Date: 2024-08-14 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 1666.67 - Is Kind Support: False Source: Daiichi Sankyo, Inc. - Amount: 26666.67 - Is Kind Support: False Source: Novartis Corporation Pharmaceuticals - Amount: 16666.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest